← FDA DRUG APPROVALS

FDA NDA · NDA020205

PSORCON

Sponsor: TARO PHARMS NORTH

APPLICATION
NDA020205
TYPE
NDA
ORIGINAL APPROVAL
1992-11-20
LATEST ACTION
1999-12-30
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

PSORCON · ReferenceDiscontinued
DIFLORASONE DIACETATE 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CREAM · TOPICAL

Approval history

1999-12-30Manufacturing (CMC) · Supplement 2 · standardAP
1997-10-10Manufacturing (CMC) · Supplement 1 · standardAP
1992-11-20Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →